Vishal Bhatnagar
United States Food and Drug Administration
ORCID: 0000-0003-4650-0513Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 10 papers. Top paper: “US Food and Drug Administration Approval Summary: Capivasertib With Fulvestrant for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Locally Advanced or Metastatic Breast Cancer With PIK3CA / AKT1 / PTEN Alterations”.
James Buturla, Christy Osgood, Xin Gao, Wei Chen, Tiffany K. Ricks +14 more
Brian L. Heiss, Hee‐Koung Joeng, Chana Weinstock, Xin Gao, William F. Pierce +8 more
Vishal Bhatnagar, Brie N. Noble, Tingyu Chen, Mallorie H. Fiero, Ron Hoffman +11 more
Laura Lee Johnson, Mallorie H. Fiero, Flora Mulkey, Paul Kluetz, Vishal Bhatnagar
Dianne Pulte, Lori A. Ehrlich, Alexei Ionan, Spencer R. Haupert, Jonathon Vallejo +15 more
Amy Barone, Stephanie Aungst, Claudia P. Miller, Suryatheja Ananthula, Youwei Bi +20 more
Ajay Major, Vishal Bhatnagar, Amylou C. Dueck, Karin E. Smedby, Tarec Christoffer El‐Galaly +8 more
Yvette L. Kasamon, Wenjuan Gu, Lisa R. Rodriguez, Susan Jin, Vishal Bhatnagar +5 more
Robert A. Avery, Michael J. Fisher, Roger J. Packer, Karin S. Walsh, Antoinette Y. N. Schouten‐van Meeteren +8 more
Mirat Shah, Lijun Zhang, Joyce Cheng, Mary Kate Bonner, Melissa A. Pegues +22 more